arrow-right cart chevron-down chevron-left chevron-right chevron-up close menu minus play plus search share user email pinterest facebook instagram snapchat tumblr twitter vimeo youtube subscribe dogecoin dwolla forbrugsforeningen litecoin amazon_payments american_express bitcoin cirrus discover fancy interac jcb master paypal stripe visa diners_club dankort maestro trash
For professional use only
AbC-19™ COVID-19 Neutralising Antibody Test

AbC-19™ COVID-19 Neutralising Antibody Test

Results in 20 mins
Fingerprick blood
Clinically validated
CE marked

In each box:

25 x AbC test cassettes

25 x blood collection pipettes

25 x lancets

25 x individual buffer tubes

1 x product insert

The AbC-19™️ Neutralising Antibody Rapid Test has been designed to address the vital market need to determine the presence of antibodies to the SARS-CoV-2 virus (COVID-19).

A solid testing regime can demonstrate whether patients have responded to a vaccination in the right way or to prove a prior infection with SARS-CoV-2. In fact, certain European countries are using this testing regime to decide whether a person will receive a single dose vaccine rather than two.

It can also be used over a period of time to establish whether antibodies are still present.

This test is designed for professional use and to be administered at point of care, by a trained healthcare professional.

Suitable for workplace testing, healthcare testing programmes, vaccination efficiency programmes, travel, events and education.

The AbC-19™️ Rapid Test is able to accurately confirm that IgG antibodies, to the full spike protein, have been produced from either an immune response to the vaccine or from recovery from a previous COVID-19 infection.

This COVID-19 IgG antibody rapid test is CE Marked for professional use only, and can be delivered at the point of care, providing accurate results in 20 minutes.

This test does not test for current infection.

The AbC-19 Rapid Test is a lateral flow test that detects specific neutralising antibodies to the SARS-CoV-2 virus with just a small finger prick of blood.

As it detects the presence of spike protein specific neutralising antibodies, it identifies the antibodies generated by an immune response that either recovery from COVID-19 or the response that virtually all vaccines engender.

The AbC-19™️ Rapid Test is proven to be effective at detecting IgG neutralising antibodies produced by your body in response to a previous COVID-19 infection or vaccination.

The AbC-19™️ test is proven to be 97.6% sensitive and has a clinical specificity of 99.6%.